Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Go back to Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update| (NASDAQ: KALA) | Delayed: 3.61 +0.76 (26.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.85 | 52 Week High | $ | |||
| Open | $2.85 | 52 Week Low | $ | |||
| Day High | $3.66 | P/E | N/A | |||
| Day Low | $2.85 | EPS | $ | |||
| Volume | 959,166 | |||||

